.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

David Capper

Berlin, DE

Charité University Hospital Berlin

Chair

12/09/2023
14:15 – 15:30
Education Day - Workshop
DNA-methylation profiling for CNS tumors: expert real life experience including “EPIC fails”
Education Day
Robert Koch (5th floor, 90 seats)
13/09/2023
13:30 – 14:30
Scientific session - Cross-field
Moving forward: Neuropathological highlights since ICN 2018
Lecture Hall (2nd floor)
large auditorium, 500 seats
Muscle and Nerve, Neurodegeneration, Neuroimmunology, Neurooncology

Speaker

12/09/2023
14:15 – 14:45 25 Min. 5 Min.
Invited Talk
Five years experience with the Heidelberg brain tumor classifier
13/09/2023
13:00 – 13:05 5 Min. 0 Min.
Special Talk
Welcoming address David Capper (Congress President)
16/09/2023
12:25 – 12:30 5 Min. 0 Min.
Special Talk
Neurooncology
16/09/2023
12:30 – 12:45 15 Min. 0 Min.
Special Talk
Closing remarks

Further involvements

14/09/2023
ePoster
PS1-NO-A55
Characterisation of gene fusions in MYB(L1)-altered gliomas
14/09/2023
ePoster
PS2-NO-A42
Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas
14/09/2023
ePoster
S14-OT-A327
Conumee 2.0 – enhanced copy-number variation analysis from DNA methylation arrays for humans and mice
14/09/2023
ePoster
S14-ND-A160
DNA methylation differences in Alzheimer's Disease neuropathology in old age – a comprehensive brain region survey
14/09/2023
ePoster
eP-NO-A88
Epigenetic and genetic characterization of T-cell lymphomas
14/09/2023
ePoster
PS1-NO-A53
VGLL-altered CNS schwannoma is a new tumor entity with distinct DNA-methylation profile and recurrent gene fusions of either VGLL3 or VGLL1
14/09/2023
ePoster
eP-NO-A92
DNA methylation-based classification of pituitary carcinomas
14/09/2023
ePoster
S14-NO-A36
Mean global DNA methylation serves as independent prognostic marker in glioblastoma, IDH wildtype
14/09/2023
ePoster
eP-NO-A83
Molecular characterization of precursor lesions of High Grade Astrocytoma with Piloid Features (HGAP)
14/09/2023
ePoster
PS7-NO-A70
Rapid DNA methylation-based classification of pediatric brain tumours from ultrasonic aspirate specimens
14/09/2023
ePoster
PS1-NO-A56
Molecular characteristics and prognostic biomarkers of central neurocytoma
14/09/2023
12:51 – 12:57 4 Min. 2 Min.
ePoster Talk
PS2-NO-A42
Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas
14/09/2023
12:57 – 13:03 4 Min. 2 Min.
ePoster Talk
eP-NO-A83
Molecular characterization of precursor lesions of High Grade Astrocytoma with Piloid Features (HGAP)
14/09/2023
13:09 – 13:15 4 Min. 2 Min.
ePoster Talk
PS1-NO-A53
VGLL-altered CNS schwannoma is a new tumor entity with distinct DNA-methylation profile and recurrent gene fusions of either VGLL3 or VGLL1
14/09/2023
13:21 – 13:27 4 Min. 2 Min.
ePoster Talk
PS1-NO-A55
Characterisation of gene fusions in MYB(L1)-altered gliomas
14/09/2023
13:27 – 13:33 4 Min. 2 Min.
ePoster Talk
PS1-NO-A56
Molecular characteristics and prognostic biomarkers of central neurocytoma
14/09/2023
17:30 – 17:36 4 Min. 2 Min.
Flash Talk
S14-NO-A36
Mean global DNA methylation serves as independent prognostic marker in glioblastoma, IDH wildtype
14/09/2023
17:36 – 17:42 4 Min. 2 Min.
Flash Talk
S14-OT-A327
Conumee 2.0 – enhanced copy-number variation analysis from DNA methylation arrays for humans and mice
14/09/2023
18:54 – 19:00 4 Min. 2 Min.
Flash Talk
S14-ND-A160
DNA methylation differences in Alzheimer's Disease neuropathology in old age – a comprehensive brain region survey
15/09/2023
13:15 – 13:21 4 Min. 2 Min.
ePoster Talk
PS7-NO-A70
Rapid DNA methylation-based classification of pediatric brain tumours from ultrasonic aspirate specimens
15/09/2023
18:10 – 18:20 7 Min. 3 Min.
Abstract Talk
S24-NO-A17
A novel type of IDH-wildtype glioma characterized by highly diffuse growth pattern, distinct epigenetic profile and relatively favorable prognosis
15/09/2023
18:20 – 18:30 7 Min. 3 Min.
Abstract Talk
S24-NO-A20
Epigenetically defined angiocentric gliomas may lack angiocentric growth and instead show a variety of growth patterns